Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C)

@inproceedings{Visser2011CharacterisationON,
  title={Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C)},
  author={M. E. Visser and E. Kropman and Mariette E G Kranendonk and Arjen Koppen and Nicole Hamers and E. S. G. Stroes and Eric Kalkhoven and Houshang Monajemi},
  booktitle={Diabetologia},
  year={2011}
}
Familial partial lipodystrophy (FPLD) is a rare metabolic disorder with clinical features that may not be readily recognised. As FPLD patients require a specific therapeutic approach, early identification is warranted. In the present study we aimed to identify cases of FPLD among non-obese patients with type 2 diabetes mellitus and marked insulin resistance. We searched the databases of three diabetic outpatient clinics for patients with marked insulin resistance, arbitrarily defined as the use… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Long - term efficacy of leptin replacement in patients with Dunnigan - type familial partial lipodystrophy

  • AR Frisancho
  • Metabolism
  • 1981

Similar Papers

Loading similar papers…